| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 62,595 shares worth roughly $5.2M.
TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 830.9K | $75.00M | - | |
| Dir | 94.5K | $7.56M | - | |
| COO | 78.5K | $6.68M | - | |
| Other | 64.0K | $4.29M | - | |
| Other | 61.5K | $4.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Link William J Phd | Director | Sale+OE | 12,500 | $78.38 | $979,744.41 | -11.7% | - | - | |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 13,953 | $87.50 | $1,220,885.00 | -77.1% | - | - | |
| Sep 4, 2026 | Neervannan Seshadri | Chief Operating Officer | Sell | 4,564 | $85.00 | $387,940.00 | -5.5% | - | - | |
| Sep 4, 2026 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 10,000 | $90.56 | $905,600.00 | -1.2% | - | - | |
| Sep 2, 2026 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 10,000 | $80.06 | $800,600.00 | -1.2% | - | - | |
| Sep 2, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 11,578 | $77.56 | $897,989.86 | -39.0% | - | - | |
| Jun 17, 2026 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 10,000 | $61.55 | $615,488.26 | -1.2% | - | - | |
| Jun 16, 2026 | Farrow Jeffrey S | See Remarks | Sale+OE | 14,396 | $60.95 | $877,436.20 | -20.2% | - | - | |
| Jun 15, 2026 | Link William J Phd | Director | Sell | 12,500 | $62.12 | $776,495.16 | -10.5% | - | - | |
| Jun 15, 2026 | Goodrich Katherine | Director | Sell | 2,954 | $62.08 | $183,384.32 | -57.0% | - | - |